ICIs quick Flashcards

1
Q

Waterhouse 95

A

ctla4 ko

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Leach 96

A

anti ctla ab tumour rej

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

hodi 2010

A

pIII antictla4 ab plateau

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

robert 11

A

I+D or D+P pIII trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Robert 15

A

N vs D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Larkin 2015

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alexandrov 13

A

TMB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Snyder 2014

A

high fitness neoantigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Marabelle 2020

A

clin trial high tmb = high survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Gurajao 2020

A

preprint

small no. tumour types and wrong FDA cut-off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Le 2015

A

MMRd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Zaretsky 2016

A

specific jak mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Chowell 2018

A

pt germline gen

HLA-I het

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ttopalian 2012

A

PD1 ex as pred of pt resp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sunshine and Taube 2015

A

PD1 not a good marker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tumeh 2014

A

TIL densty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

De Henau 2016

A

MDSCs and Pi3Ky inhibitors

19
Q

Matson 2018

A

microbiota

20
Q

Papadopoulos 2019

A

LAG-3

21
Q

Ribas 2017

A

oncolytic virus

22
Q

Valero 20211

A

N:L ratio

23
Q

ctla4 ko

A

Waterhouse 95

24
Q

anti ctla ab tumour rej

A

Leach 96

25
Q

pIII antictla4 ab plateau

A

hodi 2010

26
Q

I+D or D+P pIII trial

A

robert 11

27
Q

N vs D

A

Robert 15

28
Q

COMB

A

Larkin 2015

29
Q

TMB

A

Alexandrov 13

30
Q

high fitness neoantigens

A

Snyder 2014

31
Q

clin trial high tmb = high survival

A

Marabelle 2020

32
Q

preprint

small no. tumour types and wrong FDA cut-off

A

Gurajao 2020

33
Q

MMRd

A

Le 2015

34
Q

specific jak mutations

A

Zaretsky 2016

35
Q

pt germline gen

HLA-I het

A

Chowell 2018

36
Q

PD1 ex as pred of pt resp

A

ttopalian 2012

37
Q

PD1 not a good marker

A

Sunshine and Taube 2015

38
Q

TIL densty

A

Tumeh 2014

39
Q

MDSCs and Pi3Ky inhibitors

A

De Henau 2016

40
Q

microbiota

A

Matson 2018

41
Q

LAG-3

A

Papadopoulos 2019

42
Q

oncolytic virus

A

Ribas 2017

43
Q

N:L ratio

A

Valero 20211